Actively Recruiting

Age: 18Years +
All Genders
ID07435285

Analysis of Inflammatory Biomarker Changes in Dry Blood Spot Versus Venous Blood Samples

Led by McGill University Health Centre/Research Institute of the McGill University Health Centre · Updated on 2026-03-27

50

Participants Needed

1

Research Sites

N/A

Total Duration

On this page

Sponsors

M

McGill University Health Centre/Research Institute of the McGill University Health Centre

Lead Sponsor

S

Sensifai Health

Collaborating Sponsor

AI-Summary

What this Trial Is About

Researchers are evaluating whether dried blood spot (DBS) samples can measure changes in inflammatory biomarkers as accurately as traditional venous blood samples. The study focuses on comparing these two methods following controlled physiological stressors, such as vaccination or planned events that can temporarily raise inflammation. This research aims to determine if DBS can serve as a reliable, less invasive alternative for measuring inflammation in both acute and chronic settings. The study involves collecting both venous blood samples and DBS samples from participants. Venous samples will be processed and stored under controlled conditions, while DBS samples will be collected via finger prick onto filter paper, dried, and stored with desiccants following validated guidelines. The researchers will use a comprehensive panel that measures 48 inflammatory biomarkers to compare the results from both sample types after exposure to a physiological stressor. Participants will undergo sampling from enrollment through three days after their exposure to the stressor. Researchers will assess the agreement between inflammatory biomarker concentrations measured in DBS and venous samples. The study includes monitoring biomarker changes over this period, which helps evaluate the quality, sensitivity, and reproducibility of DBS compared to venous blood sampling. The total participation duration spans from enrollment until three days post-stressor exposure.

CONDITIONS

Brief Title

Analysis of Inflammatory Biomarker Changes in Dry Blood Spot Versus Venous Blood Samples

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Men or women aged 18 years or older
  • Planning to receive a seasonal vaccine or have a scheduled acute stressor such as hard exercise, social event with moderate alcohol, medication change, menstruation onset, or other planned stressors
Not Eligible

You will not qualify if you...

  • Infectious symptoms (fever, cough, rhinorrhea, sore throat, diarrhea, loss of smell or taste) within the previous 7 days
  • Recent or active use of cocaine, injection drugs, or amphetamines
  • Acute worsening of a known chronic health condition within the previous 30 days (e.g., IBD, COPD, asthma, rheumatologic disease)
  • Known severe allergy or intolerance to the planned vaccine
  • Contraindication to the vaccine received, if applicable

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

1 visit (in-person)

Diagnostic Evaluation

Duration - Up to 3 days after exposure to the stressor

Participants provide venous blood and dried blood spot samples following a controlled physiological stressor to measure inflammatory biomarker changes.

1 to 2 visits depending on the timing of sample collection

Long-term Monitoring

Duration - Up to 3 days after exposure to the stressor

Participants' inflammatory biomarkers are observed through collected samples to compare changes over time.

Additional sample collections may occur within this period

Trial Site Locations

Total: 1 location

1

Research Institute of the McGill University Health Centre

Montreal, Quebec, Canada, H4A 0B1

Actively Recruiting

Loading map...

Research Team

K

Kristen Moran, BSc.

E

Evelyn Laferrière, BSc.

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

0

Similar Trials

Anakinra Pilot 2 - Optimising Dose and Administration Route ...

Premature Infants

Actively Recruiting

2 locations

Functional Respiratory Tract Dysfunctions in Individuals Wit...

Obesity & Overweight

Actively Recruiting

1 location

Association Between Cytokines Gene Single Nucleotide Polymor...

Asthma in Children

Actively Recruiting

1 location

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here